Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jupiter Wellness Inc (NQ: JUPW )

0.8520 -0.0260 (-2.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,119
Open 0.8700
Bid (Size) 0.8520 (11)
Ask (Size) 0.8700 (11)
Prev. Close 0.8780
Today's Range 0.8301 - 0.8800
52wk Range 0.6296 - 4.930
Shares Outstanding 21,901,528
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Health & Wellness NASDAQ Brand, 3 Million $ Acquisition, 5 M Dollar Share Buyback Plus: Jupiter Wellness (NASDAQ: JUPW)
Via Get News
Health and Wellness NASDAQ Brand, 3 Million Dollar Acquisition, 5 Million Dollar Share Buyback Plus Featured on CNN, ABC, CBS, Bloomberg, Washington Post, Vogue and Forbes: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Viz Release

Performance

YTD
-9.65%
-9.65%
1 Month
-23.93%
-23.93%
3 Month
-29.00%
-29.00%
6 Month
-41.64%
-41.64%
1 Year
-80.05%
-80.05%

More News

Read More
Jupiter Wellness, Inc. (NASDAQ: JUPW) to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
Via AB Newswire
Jupiter Wellness, Inc. (NASDAQ: JUPW) will present data for Jupiter’s JW-300, a cannabidiol topical treatment for first degree burns, at SCALE 2022 Aesthetic Medicine
Via Get News
Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
From Jupiter Wellness, Inc.
Via AccessWire
Undervalued NASDAQ Company to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Viz Release
Jupiter Wellness Inc (NASDAQ: JUPW) Is Set To Offer Clinical Research Services, With the 3 million dollar acquisition of Acquired Ascent Clinical Research
Via AB Newswire
Jupiter Wellness To Offer Clinical Research Services With Acquisition Of Ascent Clinical Research
Via Benzinga
Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter
From Jupiter Wellness, Inc.
Via AccessWire
3 Million Dollar Acquisition, CBD Therapeutics and Wellness Products Featured on The Today Show, CNN, ABC, CBS, Animal Planet, AdWeek, Bloomberg, Washington Post, Vogue, BuzzFeed, and Forbes: Jupiter Wellness, Inc. (NASDAQ: JUPW)
Via Viz Release
Cannabis Movers & Shakers: SuperNet, MediPharm, Le-Vel, Jupiter Wellness, Leafly, Acreage
Via Benzinga
Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health and Wellness Brands
From Jupiter Wellness, Inc.
Via AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
16 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
From Jupiter Wellness, Inc.
Via AccessWire
Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
64 Biggest Movers From Friday
Via Benzinga
34 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Via Benzinga
Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga
From Jupiter Wellness, Inc.
Via AccessWire
Benzinga Announces This Week's All Access Guests
Via Benzinga
Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.